Clinical Trials Directory

Trials / Completed

CompletedNCT02529631

RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity

Randomized, Double-blind, Clinical Investigation to Compare Orlistat 60 mg and a Customized Polyglucosamine, Two Treatment Methods for the Management of Overweight and Obesity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Certmedica International GmbH · Industry
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Accepted

Summary

This trial compares two treatment methods: 1. Orlistat 60 mg to be taken three times daily one capsule; indicated for weight loss in overweight adults. Important is also that it is taken along with a reduced-calorie and low-fat diet. 2. Polyglucosamine tablets to be taken two times daily two tablets, taken with the two main meals with the highest fat content, indicated for weight maintenance and weight loss.

Conditions

Interventions

TypeNameDescription
DRUGorlistat 60 mgIn order to have comparable calorie intakes, all participants followed the recommendations of the German clinical practice guidelines on the management and prevention of obesity. Due to the different appearance of tablets and capsules, a double dummy design was chosen, a blister strip for each day and each participant had to take the same amount of capsules and tablets per day. The content of the blister strips: three orlistat 60 g capsules plus six placebo tablets.
DEVICEpolyglucosamineIn order to have comparable calorie intakes, all participants followed the recommendations of the German clinical practice guidelines on the management and prevention of obesity. Due to the different appearance of tablets and capsules, a double dummy design was chosen, a blister strip for each day and each participant had to take the same amount of capsules and tablets per day. The content of the blister strips: three blue placebo capsules plus two placebo tablets (morning) and four polyglucosamine tablets (noon and evening).

Timeline

Start date
2009-11-01
Primary completion
2010-06-01
Completion
2013-08-01
First posted
2015-08-20
Last updated
2015-08-20

Locations

2 sites across 2 countries: Germany, Italy

Source: ClinicalTrials.gov record NCT02529631. Inclusion in this directory is not an endorsement.